The contribution of transplantation to the treatment of liver tumors in children

Jean Bernard Otte, Jean De Ville De Goyet

Research output: Contribution to journalArticle

Abstract

Major progress has been achieved during the last decades in the treatment of malignant liver tumors in children, both in chemotherapy and surgical management. Chemosensitivity varies between tumor types, and radical resection remains essential to effect a cure. In tumors extensively involving a normal liver, in a diffuse or multifocal manner, radical resection cannot be accomplished with a partial hepatectomy. This has been the case for some instances of advanced hepatoblastoma and epithelioid hemangioendothelioma. In hepatoblastoma, current experience shows that results of primary liver transplantation with neoadjuvant chemotherapy are excellent with around an 80% 5-to-10-year disease-free survival rate. Epithelioid hemangioendothelioma is very rarely seen in children and may have a more malignant behavior than in adult patients, and liver transplantation may not be the best management option. In nonresectable hepatocellular carcinoma (HCC) developed on an otherwise normal liver, the results of liver transplantation are similarly poor to those obtained in adult patients, except in a few highly selected series fulfilling the Milano criteria. The experience with HCC is still very scarce in children. Incidental HCC associated with chronic liver disease does not seem to impact posttransplant survival. When they are symptomatic, however, indications for transplantation should be very selective regarding tumor size, multifocality, vascular invasion and distant metastases.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalSeminars in Pediatric Surgery
Volume14
Issue number4
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Transplantation
Epithelioid Hemangioendothelioma
Liver Transplantation
Hepatoblastoma
Hepatocellular Carcinoma
Liver
Neoplasms
Drug Therapy
Hepatectomy
Therapeutics
Disease-Free Survival
Blood Vessels
Liver Diseases
Chronic Disease
Survival Rate
Neoplasm Metastasis
Survival

Keywords

  • Children
  • Epithelioid hemangioendothelioma
  • Hepatoblastoma
  • Hepatocellular carcinoma
  • Liver tumors
  • Transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The contribution of transplantation to the treatment of liver tumors in children. / Otte, Jean Bernard; De Ville De Goyet, Jean.

In: Seminars in Pediatric Surgery, Vol. 14, No. 4, 11.2005, p. 233-238.

Research output: Contribution to journalArticle

@article{fbaf5b8fece94ec4b60a30abb6d83cb4,
title = "The contribution of transplantation to the treatment of liver tumors in children",
abstract = "Major progress has been achieved during the last decades in the treatment of malignant liver tumors in children, both in chemotherapy and surgical management. Chemosensitivity varies between tumor types, and radical resection remains essential to effect a cure. In tumors extensively involving a normal liver, in a diffuse or multifocal manner, radical resection cannot be accomplished with a partial hepatectomy. This has been the case for some instances of advanced hepatoblastoma and epithelioid hemangioendothelioma. In hepatoblastoma, current experience shows that results of primary liver transplantation with neoadjuvant chemotherapy are excellent with around an 80{\%} 5-to-10-year disease-free survival rate. Epithelioid hemangioendothelioma is very rarely seen in children and may have a more malignant behavior than in adult patients, and liver transplantation may not be the best management option. In nonresectable hepatocellular carcinoma (HCC) developed on an otherwise normal liver, the results of liver transplantation are similarly poor to those obtained in adult patients, except in a few highly selected series fulfilling the Milano criteria. The experience with HCC is still very scarce in children. Incidental HCC associated with chronic liver disease does not seem to impact posttransplant survival. When they are symptomatic, however, indications for transplantation should be very selective regarding tumor size, multifocality, vascular invasion and distant metastases.",
keywords = "Children, Epithelioid hemangioendothelioma, Hepatoblastoma, Hepatocellular carcinoma, Liver tumors, Transplantation",
author = "Otte, {Jean Bernard} and {De Ville De Goyet}, Jean",
year = "2005",
month = "11",
doi = "10.1053/j.sempedsurg.2005.06.006",
language = "English",
volume = "14",
pages = "233--238",
journal = "Seminars in Pediatric Surgery",
issn = "1055-8586",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - The contribution of transplantation to the treatment of liver tumors in children

AU - Otte, Jean Bernard

AU - De Ville De Goyet, Jean

PY - 2005/11

Y1 - 2005/11

N2 - Major progress has been achieved during the last decades in the treatment of malignant liver tumors in children, both in chemotherapy and surgical management. Chemosensitivity varies between tumor types, and radical resection remains essential to effect a cure. In tumors extensively involving a normal liver, in a diffuse or multifocal manner, radical resection cannot be accomplished with a partial hepatectomy. This has been the case for some instances of advanced hepatoblastoma and epithelioid hemangioendothelioma. In hepatoblastoma, current experience shows that results of primary liver transplantation with neoadjuvant chemotherapy are excellent with around an 80% 5-to-10-year disease-free survival rate. Epithelioid hemangioendothelioma is very rarely seen in children and may have a more malignant behavior than in adult patients, and liver transplantation may not be the best management option. In nonresectable hepatocellular carcinoma (HCC) developed on an otherwise normal liver, the results of liver transplantation are similarly poor to those obtained in adult patients, except in a few highly selected series fulfilling the Milano criteria. The experience with HCC is still very scarce in children. Incidental HCC associated with chronic liver disease does not seem to impact posttransplant survival. When they are symptomatic, however, indications for transplantation should be very selective regarding tumor size, multifocality, vascular invasion and distant metastases.

AB - Major progress has been achieved during the last decades in the treatment of malignant liver tumors in children, both in chemotherapy and surgical management. Chemosensitivity varies between tumor types, and radical resection remains essential to effect a cure. In tumors extensively involving a normal liver, in a diffuse or multifocal manner, radical resection cannot be accomplished with a partial hepatectomy. This has been the case for some instances of advanced hepatoblastoma and epithelioid hemangioendothelioma. In hepatoblastoma, current experience shows that results of primary liver transplantation with neoadjuvant chemotherapy are excellent with around an 80% 5-to-10-year disease-free survival rate. Epithelioid hemangioendothelioma is very rarely seen in children and may have a more malignant behavior than in adult patients, and liver transplantation may not be the best management option. In nonresectable hepatocellular carcinoma (HCC) developed on an otherwise normal liver, the results of liver transplantation are similarly poor to those obtained in adult patients, except in a few highly selected series fulfilling the Milano criteria. The experience with HCC is still very scarce in children. Incidental HCC associated with chronic liver disease does not seem to impact posttransplant survival. When they are symptomatic, however, indications for transplantation should be very selective regarding tumor size, multifocality, vascular invasion and distant metastases.

KW - Children

KW - Epithelioid hemangioendothelioma

KW - Hepatoblastoma

KW - Hepatocellular carcinoma

KW - Liver tumors

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=26644439293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26644439293&partnerID=8YFLogxK

U2 - 10.1053/j.sempedsurg.2005.06.006

DO - 10.1053/j.sempedsurg.2005.06.006

M3 - Article

C2 - 16226698

AN - SCOPUS:26644439293

VL - 14

SP - 233

EP - 238

JO - Seminars in Pediatric Surgery

JF - Seminars in Pediatric Surgery

SN - 1055-8586

IS - 4

ER -